Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Exploratory Analyses from the Phase Three INDIGO Study Suggest Potential Mechanism of Seizure Control Through Tumor Volume Reduction Under Treatment With Vorasidenib

Author:Peters, Katherine   Mellinghoff, Ingo   Wick, Wolfgang   Van Den Bent, Martin   Blumenthal, Deborah   Touat, Mehdi   Clarke, Jennifer   Mendez, Joe   Welsh, Liam   Mason, Warren   Hottinger, Andreas   Sepulveda, Juan   Soffietti, Riccardo   Zhao, Dan   Yi, Denise   Weidl, Daniel   Steelman, Lori   Hassan, Islam   Wen, Patrick   Cloughesy, Timothy   

Session Name:S28: Neuro-oncology: Clinical and Practice Updates  

Topic:Neuro-oncology  

Program Number:S28.002  

Author Institution:Duke University Medical Center, Durham, NC  Memorial Sloan Kettering Cancer Center, New York, NY  Universitätsklinikum Heidelberg, Heidelberg & German Cancer Research Center, Heidelberg, Germany  Erasmus Medical Center, Rotterdam, Netherlands  Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel  Pitié Salpêtrière Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP) Sorbonne Université, Paris, France  UCSF, San Francisco, CA  Huntsman Cancer, Salt Lake City, UT  The Royal Marsden Hospital, London, United Kingdom  Toronto General Hospital, Toronto, ON, Canada  University Hospital of Lausanne, Lausanne, Switzerland  Hospital Universitario 12 de Octubre, Madrid, Spain  University of Turin, Torino, Italy  Servier Pharmaceuticals, CAMBRIDGE, MA  Servier Pharmaceuticals, Boston, MA  Servier Deutschland GmbH, Munich, Germany  Servier Pharmaceuticals, Wilmington, MA  Dana-Farber/Brigham and Women'S Cancer Center, Boston, MA  University of California Los Angeles, Los Angeles, CA